EnClear Therapies

📍 Newburyport, United States🗓 Founded 2018👥 14 employees💰 Last funded Mar 2019
Medical Device🌐 encleartherapies.com
Website LinkedIn
At EnClear Therapies, we are combining Bioscience & Med-tech expertise to develop solutions that improve and extend the lives of patients with CNS disease. The team at EnClear is developing systems and medical interventions that Access, Recirculate & Modify CSF for: › Targeted removal of toxicity from CSF correlated to neurodegenerative disease progression. › Continuous localized delivery of therapeutics & monitoring of CSF to ensure effective and personalized therapy.
3
Total investors
3
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
2
Australia
1
Frequently asked questions
Who invested in EnClear Therapies?
EnClear Therapies has 3 investors on record on gritt.io, including 3 early-stage backers.
When did EnClear Therapies last raise funding?
The most recent investment in EnClear Therapies recorded on gritt.io was in March 2019.
When was EnClear Therapies founded?
EnClear Therapies was founded in 2018.
What industry is EnClear Therapies in?
EnClear Therapies operates in Medical Device. Find similar Medical Device investors on gritt.io.
Where is EnClear Therapies based?
EnClear Therapies is headquartered in Newburyport, United States.